LLY Eli Lilly and Company
Healthcare$1065.00+2.24%ClosedMarket Cap: $1.00T
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$1,263.74
Target (Median)
$1,280.00
Target Range
$1,070.00 - $1,400.00
Upside from current price: 18.7%
Rating Distribution
6 Strong Buy18 Buy6 Hold1 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-05 | Barclays | maintain | Overweight | Overweight |
| 2026-05-05 | Guggenheim | maintain | Buy | Buy |
| 2026-05-04 | Wolfe Research | maintain | Outperform | Outperform |
| 2026-05-01 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| 2026-04-10 | Morgan Stanley | maintain | Overweight | Overweight |
| 2026-04-02 | B of A Securities | maintain | Buy | Buy |
| 2026-03-30 | Guggenheim | maintain | Buy | Buy |
| 2026-03-17 | HSBC | downgrade | Reduce | Hold |
| 2026-02-10 | Freedom Broker | upgrade | Buy | Hold |
| 2026-02-09 | Deutsche Bank | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $44.40 | $98.19B | 16 |
| Sun Dec 31 | $50.99 | $109.66B | 8 |
| Mon Dec 31 | $57.17 | $120.10B | 6 |
| Tue Dec 31 | $62.90 | $130.61B | 6 |